MARKET

GSK

GSK

GSK PLC
NYSE
48.71
-0.07
-0.14%
After Hours: 48.79 +0.08 +0.17% 19:11 12/17 EST
OPEN
49.35
PREV CLOSE
48.78
HIGH
49.44
LOW
48.68
VOLUME
5.26M
TURNOVER
--
52 WEEK HIGH
49.44
52 WEEK LOW
30.40
MARKET CAP
99.32B
P/E (TTM)
13.57
1D
5D
1M
3M
1Y
5Y
1D
Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK)
TipRanks · 21h ago
UK’s $49 Billion R&D Plan Puts Quantum Tech on Investors’ Radar
TipRanks · 21h ago
GSK announces FDA approval of Exdensur for severe asthma treatment
TipRanks · 1d ago
GSK wins FDA approval for Exdensur in severe eosinophilic asthma
Seeking Alpha · 1d ago
UK Stocks-Factors to watch on December 17
Reuters · 1d ago
CDC signs off on change in newborn hepatitis b vaccine schedule
Seeking Alpha · 1d ago
FDA Approves GSK’s Exdensur for Severe Eosinophilic Asthma
Reuters · 1d ago
EXDENSUR (DEPEMOKIMAB) APPROVED BY US FDA FOR THE TREATMENT OF SEVERE ASTHMA
Reuters · 1d ago
More
About GSK
GSK plc is a biopharma company. The Company’s segments include Commercial Operations and Research and Development. Its portfolio and pipeline are focused on developing medicines and vaccines in four core therapeutic areas, which are the areas of human health it focuses on to prevent and treat disease: respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Its vaccine portfolio includes over 20 vaccines to protect people from diseases and infections throughout their lives. General medicines include inhaled medicines for asthma and COPD to antibiotics. It develops and commercializes preclinical antibody-drug conjugate for Metastatic castration-resistant prostate cancer. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development.

Webull offers GSK plc (ADR) stock information, including NYSE: GSK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GSK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GSK stock methods without spending real money on the virtual paper trading platform.